News

BioMarin Strengthens Enzyme Therapy Business with Acquisition of Inozyme Pharma
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) and Inozyme Pharma, Inc. (Nasdaq: INZY) announced today that BioMarin has entered into a definitive agreement to acquire Inozyme for $4.00 per share in an ...
MotorTrend on MSN59m
Chrysler Halcyon Concept First Look: Six Doors and Sci-Fi Tech
What does the Halcyon’s technology and minimalist design mean for the Chrysler brand at large? What do people really want out ...